Charlotte Hu
Articles Authored by Charlotte Hu
A pilot project showed that clinics using the InheRET tool were able to gather more complete family history information from patients, which is important for further cancer risk evaluation.
Decipher Bladder Cancer Test Determines Molecular Subtype Most Likely to Respond to Keytruda
Premium
The platform was used to subtype patients in a Phase II trial and found that patients in the claudin-low subgroup had the best two-year progression-free survival on pembrolizumab.
Germline Genetic Testing, Counseling Move Remote as Pandemic Limits In-Person Care Capacity
Many companies and counselors see the COVID-19 pandemic as a catalyst for moving germline risk testing into a digital-first healthcare model.
Perthera's Virtual Molecular Tumor Board Can Improve Patient Outcomes, Overcome Access Barriers
Premium
After a study showed that patients who received guidance from Perthera's tumor board lived longer than those who didn't, the company wants to make its technology more accessible.
CVS Health, Tempus Precision Oncology Program Aims to Aid Oncologists, Improve Patient Outcomes
Premium
The CVS-Tempus partnership aims to streamline the cancer care process for patients from the point of prescribing onwards and connect patients with local trials.
Researchers at BostonGene and Weill Cornell Medicine hope their approach may provide a more complete and precise characterization of diffuse large B-cell lymphomas.
Ambry Genetics, Mayo Clinic Develop Mutation Prevalence Tool to Guide Docs on Appropriate Testing
Premium
Currently available under a soft launch, the tool can provide information about the prevalence of cancer risk mutations based on patients' demographics.